Postdoc start-up grant: ATGL cardiomyopathy: From mechanism to a new epigenetic therapy approach
| Institution | Universität Heidelberg |
|---|---|
| Project leader | Xuemin Gong |
| Site | Heidelberg/Mannheim |
| Project type | Exzellenzprogramm |
| Funding | € 58.950,00 |
| Begin | 01.04.2020 |
| End | 31.12.2021 |
Förderkennzeichen
81X3500125
Projektnummer
1238